Ampyr 10-MG

Ended Awarded Last action

Contract number
VA26016F9100
Awardee
Awarding agency
Obligated
$339,033

Award facts

Contract value 100% obligated
$339,032.88 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
PSC
6810 Chemicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Ardsley, NY 10502, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $137,912
Original award $201,121

About this award

This is a federal contract award to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological disorders. The contract, awarded by the U.S. Department of Veterans Affairs (VA), is a delivery order under Acorda's Federal Supply Schedule (FSS) contract with the VA, valued at over $16.3 million. The specific contract award is for $339,032.88 and is for the supply of Levodopa 42mg inhalation capsules, a medication used to treat Parkinson's disease symptoms. This contract is not set aside and is awarded on an unrestricted basis. Acorda Therapeutics has also been awarded two Blanket Purchase Agreements (BPAs) by the VA National Acquisition Center, valued at $5.5 million and $7.5 million, specifically for the procurement of Inbrija and Ampyra, two other neurological medications the company manufactures. These contract vehicles facilitate the VA's ability to purchase Acorda's products to provide high-quality healthcare to veterans suffering from Parkinson's disease and multiple sclerosis.

Quick answers

Who was awarded contract VA26016F9100?

VA26016F9100 was awarded to Acorda Therapeutics, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2015.

How much is contract VA26016F9100 worth?

The government has obligated $339,033 on VA26016F9100.

Is contract VA26016F9100 an order under another contract?

Yes. VA26016F9100 is a delivery order under V797P5233B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA26016F9100 competed?

The extent of competition for VA26016F9100 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award